Vanguard Investments Australia
PAHC icon

Vanguard Investments Australia’s Phibro Animal Health PAHC Stock Holding History

Vanguard Investments Australia’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Hold
4,819
– – ﹤0.01% 2221
2026
Q1 		$267K Buy
+4,819
New +$229K ﹤0.01% 1899

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Investments Australia's PAHC Position: Q2 2026 in Review

Vanguard Investments Australia held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 4,819 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Vanguard Investments Australia first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $267K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Vanguard Investments Australia held 4,819 shares of Phibro Animal Health worth $151K as of Q2 2026.
  • Vanguard Investments Australia left its Phibro Animal Health share count unchanged in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2221 holding.
  • Vanguard Investments Australia first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Phibro Animal Health position peaked at $267K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.